Skip to search formSkip to main contentSkip to account menu

SDX-105

National Institutes of Health

Related topics

Related topics

2 relations
bendamustine

Broader (1)

bendamustine hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Mitotic catastrophe induced in cells treated with SDX-105 (Treanda™)
2291 SDX-105 (Treanda™, bendamustine), an alkylating agent with a distinct mechanism of action, is active in NHL and CLL patients… 
2004
2004
In vitro and ex vivo activity of SDX-105 (bendamustine) in drug-resistant lymphoma cells
1215 SDX-105 (bendamustine), currently in Phase II clinical trials in the US for the treatment of rituximab relapsed/resistant… 
2004
2004
SDX-105 (Treanda™) Enhances the Tumor Growth Inhibitory Effect of Rituximab in Daudi Lymphoma Xenografts.
SDX-105 (Treanda™, Bendamustine HCl), a structurally and mechanistically unique multifunctional anticancer drug, has been… 
2004
2004
SDX-105 (Treanda™), Active in Non-Hodgkin’s Lymphoma Cells, Induces the Mitotic Catastrophe Death Pathway.
SDX-105 (Treanda™) is an alkylating agent with a distinct mechanism of action that has been shown to be active in clinical trials… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)